Hong Kong Pharma [HKPD] vs SunLink Health [SSY] Detailed Stock Comparison
Hong Kong Pharma
NASDAQ
Loading...
SunLink Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Hong Kong Pharma wins in 6 metrics, SunLink Health wins in 9 metrics, with 0 ties. SunLink Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hong Kong Pharma | SunLink Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.26 | -5.07 | SunLink Health |
| Price-to-Book Ratio | 2.71 | 0.59 | SunLink Health |
| Debt-to-Equity Ratio | 47.60 | 4.98 | SunLink Health |
| PEG Ratio | N/A | 0.10 | N/A |
| EV/EBITDA | 48.49 | -0.46 | SunLink Health |
| Profit Margin (TTM) | -0.13% | 5.55% | SunLink Health |
| Operating Margin (TTM) | -9.05% | -9.33% | Hong Kong Pharma |
| Return on Equity | -0.59% | -22.34% | Hong Kong Pharma |
| Return on Assets (TTM) | 1.32% | -13.62% | Hong Kong Pharma |
| Free Cash Flow (TTM) | $414,226 | $-4.45M | Hong Kong Pharma |
| 1-Year Return | -55.27% | 33.33% | SunLink Health |
| Price-to-Sales Ratio (TTM) | 0.67 | 0.25 | SunLink Health |
| Enterprise Value | $12.90M | $1.05M | Hong Kong Pharma |
| EV/Revenue Ratio | 0.64 | 0.03 | SunLink Health |
| Gross Profit Margin (TTM) | N/A | 37.14% | N/A |
| Revenue per Share (TTM) | $2 | $4 | SunLink Health |
| Earnings per Share (Diluted) | $0.00 | $-0.39 | Hong Kong Pharma |
| Beta (Stock Volatility) | N/A | 1.15 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hong Kong Pharma vs SunLink Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hong Kong Pharma | 8.94% | -19.08% | 9.82% | -5.38% | 10.81% | -56.38% |
| SunLink Health | 16.15% | 3.70% | 15.46% | 33.33% | 16.67% | 23.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hong Kong Pharma | -55.27% | -55.27% | -55.27% | -55.27% | -55.27% | -55.27% |
| SunLink Health | 33.33% | -5.88% | 12.00% | -34.88% | -45.10% | -86.95% |
Performance & Financial Health Analysis: Hong Kong Pharma vs SunLink Health
| Metric | HKPD | SSY |
|---|---|---|
| Market Information | ||
| Market Cap | $14.28M | $6.97M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 202,230 | 246,965 |
| 90 Day Avg. Volume | 6,183,840 | 239,518 |
| Last Close | $1.34 | $1.12 |
| 52 Week Range | $0.81 - $3.79 | $0.62 - $1.91 |
| % from 52W High | -64.64% | -41.62% |
| All-Time High | $3.79 (Jan 13, 2025) | $21.00 (Jun 09, 1986) |
| % from All-Time High | -64.64% | -94.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | -0.02% |
| Quarterly Earnings Growth | N/A | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.06% |
| Operating Margin (TTM) | -0.09% | -0.09% |
| Return on Equity (TTM) | -0.01% | -0.22% |
| Debt to Equity (MRQ) | 47.60 | 4.98 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.45 | $1.91 |
| Cash per Share (MRQ) | $0.27 | $1.06 |
| Operating Cash Flow (TTM) | $569,214 | $-2,929,000 |
| Levered Free Cash Flow (TTM) | $2.16M | $1.48M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Hong Kong Pharma vs SunLink Health
| Metric | HKPD | SSY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.26 | -5.07 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 0.10 |
| Price to Sales (TTM) | 0.67 | 0.25 |
| Price to Book (MRQ) | 2.71 | 0.59 |
| Market Capitalization | ||
| Market Capitalization | $14.28M | $6.97M |
| Enterprise Value | $12.90M | $1.05M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.64 | 0.03 |
| Enterprise to EBITDA | 48.49 | -0.46 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.15 |
| Book Value per Share (MRQ) | $0.45 | $1.91 |
Financial Statements Comparison: Hong Kong Pharma vs SunLink Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HKPD | SSY |
|---|---|---|
| Revenue/Sales | N/A | $7.32M |
| Cost of Goods Sold | N/A | $4.60M |
| Gross Profit | N/A | $2.72M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $-683,000 |
| EBITDA | N/A | $-350,000 |
| Pre-Tax Income | N/A | $-630,000 |
| Income Tax | N/A | $0 |
| Net Income (Profit) | N/A | $-671,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HKPD | SSY |
|---|---|---|
| Cash & Equivalents | $748,721 | $7.47M |
| Total Current Assets | $8.73M | $13.71M |
| Total Current Liabilities | $2.92M | $3.50M |
| Long-Term Debt | $1.51M | $388,000 |
| Total Shareholders Equity | $4.99M | $13.41M |
| Retained Earnings | $1.50M | $-1.09M |
| Property, Plant & Equipment | $650,435 | $11.71M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HKPD | SSY |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | $100,000 |
| Free Cash Flow | N/A | $-654,000 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HKPD | SSY |
|---|---|---|
| Shares Short | 367,836 | 10,601 |
| Short Ratio | 0.04 | 0.05 |
| Short % of Float | 0.18% | 0.00% |
| Average Daily Volume (10 Day) | 202,230 | 246,965 |
| Average Daily Volume (90 Day) | 6,183,840 | 239,518 |
| Shares Outstanding | 11.00M | 7.04M |
| Float Shares | 3.42M | 4.66M |
| % Held by Insiders | 0.68% | 0.28% |
| % Held by Institutions | 0.01% | 0.15% |
Dividend Analysis & Yield Comparison: Hong Kong Pharma vs SunLink Health
| Metric | HKPD | SSY |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |